Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

Native American infants, with an overall incidence and severity of adverse events (AEs) that were similar between the motavizumab and the placebo groups. The mortality rates were not statistically different between groups (0.4 percent in the placebo arm, n=2 and 0.3 percent in the motavizumab arm, n=3) and were not considered to be related to the study drug. As was suggested in the pivotal Phase 3 trial conducted in high-risk, preterm infants, rates of hypersensitivity related skin rashes within two days of dosing were seen in about one percent of treated children in the motavizumab group.

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis, which was a significant product improvement as a monthly intramuscular injection for the prevention of severe RSV, as well as being the first MAb to receive U.S. Food and Drug Administration (FDA) approval for an infectious disease. With the development of motavizumab, MedImmune continues to reinforce its commitment to developing anti-RSV products. In a head-to-head comparative Phase 3 trial with Synagis, motavizumab met its primary endpoint of reducing RSV-related hospitalizations in high-risk pediatric patients and met its secondary endpoint of reducing medically attended, outpatient respiratory tract infections in that patient group. MedImmune is also developing a small-molecule product candidate to prevent RSV as well as a vaccine against RSV, both of which are in Phase 1 clinical trials.

About RSV

Each year, up to 125,000 infants in the U.S. are hospitalized with severe RSV infections, the leading cause of lower respiratory tract infections
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... NEW YORK , May 27, 2015 ... impacted by accelerated aging of population and ... and other lifestyles has been growing year after year, ... (PCI) market. PCI cases in China ... year earlier; meanwhile the interventional cardiovascular device industry there ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "Asia Pacific Ultrasound Devices ... - 2019)"  company profile to their ... , ,Ultrasound is a type of imaging. ... at body parts and structures inside the ...
(Date:5/27/2015)... 2015 Research and ... of the  "US Cancer Vaccine Market Outlook ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,Cancer ... broad categories of prophylactic (preventive) and therapeutic ... to both of these groups have been ...
Breaking Medicine Technology:China Interventional Cardiovascular Device Industry Report, 2014-2017 2China Interventional Cardiovascular Device Industry Report, 2014-2017 3Asia Pacific Ultrasound Devices Market Report 2015 - Growth, Trends And Forecasts 2014 - 2019 2US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3
... -- BERGISCH GLADBACH, Germany, September 22, 2010 ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r in ...
... With a company rank on this year,s list ... list of companies who have surpassed expectations during ... (Logo: http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) (Logo: ... List honors the fastest growing private companies in ...
Cached Medicine Technology:Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 2Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 3Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 4Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 5Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 6
(Date:5/28/2015)... Madison, Wisconsin (PRWEB) May 28, 2015 ... is hands-down the most rewarding, researched and heartfelt book ... The reviewer thanked Dr. Westman for writing what ... read. Information is power and there is power in ... ugly “c” word no one wants to talk about and ...
(Date:5/28/2015)... The second episode of “Extreme Weight Loss” ... a need to transform their lives. Josh (29 years old) ... to deal with the death of his father. Kelli (26 ... City, MO, who went into depression after her playing career ... be featured in one episode of “Extreme Weight Loss” on ...
(Date:5/27/2015)... May 28, 2015 Throughout the past few ... for research comparing the validity and reliability of the Shaw ... Nair, P.T., Ph.D., Associate Professor in the Department of Physical ... the study. , The Shaw Gait Assessment is a free ... equipment. The GaitRite is considered the gold standard in ...
(Date:5/27/2015)... Thermage was the first to come out with a non-surgical ... with the release of NXT or CPT, the second-generation of ... the first practice in New York to debut the new ... had never been achieved before non-surgically. Even today, almost ... many as the leading skin tightening device. The ...
(Date:5/27/2015)... 2015 Ticket Down is a reputable source of ... Blackhawks are currently in the middle of their series against the ... series. If the Blackhawks can win tonight at home, this ... Saturday, May 30th at the Honda Center in Anaheim. , ... in the Western Conference as they won the Pacific Division by ...
Breaking Medicine News(10 mins):Health News:Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 3Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2
... Nov. 3 The Guardian Life Insurance Company ... benefit enrollment,services by adding more features to serve ... Census Bureau, Spanish speakers constitute 12,percent of the ... has introduced customized Spanish-language benefit enrollment,kits, with everything ...
... Genoveva (“Gigi”) Garcia, a 91-year-old movie buff who once was a ... final reel in her life has a surprising twist: Her granddaughter, ... sharing her riches-to-rags-to-riches story with others on CarePages.com, a community of ... , ...
... 3 Paul Offit, MD,announced today that all author ... False Prophets: Bad Science, Risky Medicine, and the Search,for ... Autism Research at,Children,s Hospital of Philadelphia., (Photo: ... with Dr. Offit, and to accept the,royalties of his ...
... scientists have discovered a mechanism by which intracellular pathogens ... weapons against them: nitric oxide. The researchers found that ... biochemical machinery used by immune cells called macrophages to ... tanks of the immune system, attacking and consuming bacteria ...
... in detecting airway stent complications according to a recent ... Harvard Medical School in Boston, MA. , MDCT ... patients, including all cases of intraluminal narrowing, migration, invasion ... of four cases of stent fracture," according to Vandana ...
... or surgical procedures for children with suspected musculoskeletal ... study performed at Vanderbilt Children,s Hospital in Nashville, ... on 130 children with suspected musculoskeletal infections; 34 ... after diagnostic or therapeutic intervention and 96 patients ...
Cached Medicine News:Health News:Guardian Enhances Enrollment Capabilities With More Spanish Language Services 2Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 2Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 3Health News:Author Royalties From Autism Book Donated to Autism Research 2Health News:Parasites that live inside cells use loophole to thwart immune system 2Health News:Parasites that live inside cells use loophole to thwart immune system 3
... Estrone Sulfate (E1S) is the most ... well as normal men [1,2]. Estrone Sulfate ... estrone, and has a longer half-life in ... levels generally parallel those of estrone and ...
Helmer's Horizon Series line of refrigerators are designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety...
Helmer's Horizon Series line of refrigerator is designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety o...
... Helmer presents the i.Series ... innovative solutions for the ... sophisticated features than ever ... Refrigerators are at the ...
Medicine Products: